A Case of EBV Induced HLH Following Covid-19 Vaccination in a Pediatric Patient

Jacob, Seethal MD; Belsky, Jennifer DO, MS; Arand, Amanda; Overholt, Kathleen MD

MLA citation style (9th ed.)

Jacob, Seethal MD, et al. A Case of Ebv Induced Hlh Following Covid-19 Vaccination In a Pediatric Patient. . 2021. mushare.marian.edu/concern/generic_works/4b33dd58-a780-459c-ac92-cc31d0bec84e?locale=es.

APA citation style (7th ed.)

J. S. Md, B. J. D. Ms, A. Amanda, & O. K. Md. (2021). A Case of EBV Induced HLH Following Covid-19 Vaccination in a Pediatric Patient. https://mushare.marian.edu/concern/generic_works/4b33dd58-a780-459c-ac92-cc31d0bec84e?locale=es

Chicago citation style (CMOS 17, author-date)

Jacob, Seethal MD, Belsky, Jennifer DO, MS, Arand, Amanda , and Overholt, Kathleen MD. A Case of Ebv Induced Hlh Following Covid-19 Vaccination In a Pediatric Patient. 2021. https://mushare.marian.edu/concern/generic_works/4b33dd58-a780-459c-ac92-cc31d0bec84e?locale=es.

Note: These citations are programmatically generated and may be incomplete.

The COVID-19 pandemic resulted in widespread mRNA vaccinations against SARS-CoV2. Side effects include fatigue, headache, myalgia,
fever, nausea, and lymphadenopathy, frequently experienced in younger recipients (16-55 years) following the second dose. Hemophagocytic Lymphohistiocytosis (HLH) is a rare syndrome of uncontrolled systemic inflammation identified by clinical and laboratory signs of immune activation. In pediatric patients, HLH occurs in 1.2 cases per million persons per year. If untreated, HLH is often fatal, with a median survival of 2 months.

Title